Time to Nix the Primary Prevention ICD?
The REFINE-ICD trial identified patients at high arrhythmic risk post myocardial infarction, yet didn’t show a benefit for a prophylactic implantable cardioverter-defibrillator.| Medscape
The REFINE-ICD trial identified patients at high arrhythmic risk post myocardial infarction, yet didn’t show a benefit for a prophylactic implantable cardioverter-defibrillator.| Medscape
Will reassuring safety data and a good efficacy signal increase use of digoxin in heart failure? John Mandrola MD reviews the DIGIT- HF trial from the 2025 European Society of Cardiology congress.| Medscape
Seemingly conflicting data from trials on whether to use beta-blockers post myocardial infarction point in the same direction, argues John Mandrola, MD, in reviewing BETAMI/DANBLOCK and REBOOT.| Medscape
Cardiology : Welcome to theheart.org | Medscape Cardiology, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.| www.medscape.com
Study record managers: refer to the Data Element Definitions if submitting registration or results information.| www.clinicaltrials.gov
Science Podcast · Updated Weekly · This podcast delivers Dr. John Mandrola’s summary and perspective on top news of the week that cardiologists can’t miss. This podcast is intended for US health professionals only.| Apple Podcasts
David Cohen is one of the smartest docs on Twitter.| www.sensible-med.com
